XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
CNY (¥)
¥ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
CNY (¥)
¥ / shares
shares
Dec. 31, 2020
CNY (¥)
¥ / shares
shares
Revenues, net of value-added tax ¥ 472,085 $ 68,446 ¥ 485,633 ¥ 223,011
Cost of revenues (624,494) (90,543) (542,530) (209,928)
Gross profit (loss) (152,409) (22,097) (56,897) 13,083
Operating expenses:        
Selling expenses (61,479) (8,914) (53,675) (25,761)
General and administrative expenses (311,160) (45,114) (347,746) (294,823)
Impairment of long-lived assets 0   0 (8,500)
Operating loss (525,048) (76,125) (458,318) (316,001)
Interest expense (including interest expense to related party amounting to RMB41,918, RMB13,532 and RMB16,790 (US$2,434) for the years ended December 31, 2020, 2021 and 2022, respectively) (120,357) (17,450) (73,789) (81,359)
Foreign exchange gain (loss), net 54,982 7,972 (19,925) (58,686)
Gain (loss) on disposal of long-lived assets (3)     677
Interest income (including interest income from related party amounting to RMB127, RMB3,447 and RMB6,946(US$1,007) for the years ended December 31, 2019, 2020 and 2021, respectively) 10,021 1,453 5,894 8,440
Change in fair value of derivative liability 1,015 147 (39) 0
Income from equity method investments 17,647 2,559 18,163 6,021
Loss on disposal of subsidiaries (61,546) (8,923) 0 (14,894)
Other (expenses) income, net (216,607) (31,405) (1,223) 6,312
Gain on disposal of an equity method investment     0 7,837
Loss before income tax (839,896) (121,772) (529,237) (441,653)
Income tax benefit 70,906 10,280 6,565 37,624
Net loss (768,990) (111,492) (522,672) (404,029)
Net loss attributable to noncontrolling interests 279,329 40,499 251,245 94,040
Net loss attributable to Concord Medical Services Holdings Limited ¥ (489,661) $ (70,993) ¥ (271,427) ¥ (309,989)
Loss per share for Class A and Class B ordinary shares:        
Basic | (per share) ¥ (3.74) $ (0.54) ¥ (6.26) ¥ (5.11)
Diluted | (per share) ¥ (3.74) $ (0.54) ¥ (6.26) ¥ (5.11)
Weighted average number of class A and class B ordinary shares outstanding:        
Basic | shares 131,053,858 131,053,858 131,053,858 131,053,858
Diluted | shares 131,053,858 131,053,858 131,053,858 131,053,858
Other comprehensive income (loss), net of tax of nil        
Foreign currency translation, net tax of nil ¥ (53,964) $ (7,824) ¥ 14,821 ¥ 50,856
Total other comprehensive income (loss), net of tax (53,964) (7,824) 14,821 50,856
Comprehensive loss (822,954) (119,316) (507,851) (353,173)
Comprehensive loss attributable to noncontrolling interests (279,329) (40,499) (251,245) (94,040)
Comprehensive loss attributable to Concord Medical Services Holdings Limited (543,625) (78,817) (256,606) (259,133)
Equipment leasing revenues        
Revenues, net of value-added tax 21,966 3,185 42,484 52,906
Cost of revenues (18,905) (2,741) (40,539) (36,911)
Services and other revenues        
Revenues, net of value-added tax 364,412 52,835 383,828 140,050
Cost of revenues (518,500) (75,175) (441,510) (143,443)
Medicine income        
Revenues, net of value-added tax 85,707 12,426 59,321 30,055
Cost of revenues ¥ (87,089) $ (12,627) ¥ (60,481) ¥ (29,574)